Addressing the Health Needs of People Who Inject Drugs: A Descriptive Analysis of an Inpatient Integrated Care Team Within an Acute Hospital in Scotland

• by Alexandria Chung, Katya Johnson, Bethany Mulloy, Claire L Mackintosh

• March 11, 2025

Assessing HIV Vulnerability and the Use of Oral Pre-Exposure Prophylaxis (PrEP) in Injecting Drug Users in Nairobi: A Cross-Sectional Analysis

• by Cosmas Mugambi, Loice Mbogo, William Sinkele, Esther Gitau, Tecla Temu, Carey Farquhar, David Bukusi, John Kinuthia, Aliza Monroe-Wise

• January 5, 2026

Two-Drug HIV Regimen Gains FDA Approval

Phase 3 trials showed noninferior viral suppression vs standard three-drug therapy with similar safety outcomes

• by Kathryn Wighton

• April 21, 2026

• 2 min

Side Effects: Nobody Trained for This

Chemsex at the pharmacy counter. Gut bacteria tracking helmet impacts. PMD predicting psychiatric illness bidirectionally. This week's research keeps landing in the same uncomfortable place: medicine is improvising.

• by Kerri Miller

• May 11, 2026

• 6 min